ckd,kidneydisease

Mashup Score: 2

Tolvaptan Treatment for ADPKD Slows Kidney Function Decline Over the Long Term - 3 day(s) ago

Real-world data supports tolvaptan use to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).

Source: www.renalandurologynews.com

Categories: General Medicine News, Urology

Tweet Tweets with this article
- renalandurology
  
  A study of real-world patients with ADPKD supports tolvaptan’s role in slowing annual eGFR decline. https://t.co/hFOP9si1aI #ckd #kidneydisease